|
ZNF267 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.83530001885669E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.12519999999161E-05 |
| Normal-vs-Stage2 |
7.139700E-03 |
| Normal-vs-Stage3 |
1.248420E-04 |
| Normal-vs-Stage4 |
6.078600E-03 |
| Stage1-vs-Stage2 |
1.573760E-01 |
| Stage1-vs-Stage3 |
1.272840E-01 |
| Stage1-vs-Stage4 |
9.752800E-01 |
| Stage2-vs-Stage3 |
9.123000E-01 |
| Stage2-vs-Stage4 |
3.510000E-01 |
| Stage3-vs-Stage4 |
3.592600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.94079996097241E-09 |
| Normal-vs-AfricanAmerican |
8.003500E-04 |
| Normal-vs-Asian |
4.700000E-02 |
| Caucasian-vs-AfricanAmerican |
2.559600E-01 |
| Caucasian-vs-Asian |
5.603000E-01 |
| AfricanAmerican-vs-Asian |
8.571800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.55289999748121E-08 |
| Normal-vs-Female |
2.18770000000035E-05 |
| Male-vs-Female |
9.757800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.702800E-03 |
| Normal-vs-Extreme_Weight |
2.01399999999463E-05 |
| Normal-vs-Obese |
1.58400000005443E-07 |
| Normal-vs-Extreme_Obese |
1.546390E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.668800E-01 |
| Normal_Weight-vs-Obese |
1.652050E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.974600E-01 |
| Extreme_Weight-vs-Obese |
3.552000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.755000E-01 |
| Obese-vs-Extreme_Obese |
3.335800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.11590000000128E-05 |
| Normal-vs-Age(41-60Yrs) |
2.54230003715605E-09 |
| Normal-vs-Age(61-80Yrs) |
1.5405599999907E-05 |
| Normal-vs-Age(81-100Yrs) |
1.680050E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.540400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.343000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.704770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.466830E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.849780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.422800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.23490004070248E-09 |
| Normal-VS-Type2 PRCC |
1.182850E-03 |
| Normal-VS-KIRP CIMP |
1.385570E-04 |
| Normal-VS-Unclassified PRCC |
2.245300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.932100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.151200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.663000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.485400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.468500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.836000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.377970E-03 |
| Normal-vs-N1 |
1.163950E-04 |
| Normal-vs-N2 |
2.514400E-02 |
| N0-vs-N1 |
1.448130E-02 |
| N0-vs-N2 |
8.162200E-01 |
| N1-vs-N2 |
4.004000E-01 |
|
|
